Presentation Materials

Note: The Japanese version is the official document.

2025

Jun 13,2025
Chugai Open Innovation Meeting
Products / R&D
Show more

Chugai’s Open Innovation in Drug Discovery
Dr. Tomoyuki Igawa,
Vice President, Head of Research Div., Chugai Pharmaceutical Co., Ltd.
Chugai Venture Fund: Investment Overview
John Gustofson,
Head of Chugai Venture Fund, LLC
Chugai’s Partnering Activities
Yumiko Asano,
Head of Partnering Dept., Chugai Pharmaceutical Co., Ltd.
- Presentation [PDF 3.0MB]
- Script (including Q&A) [PDF 12.3MB]
Apr 24,2025
Conference on FY2025.12 Q1 Financial Results
Results
Show more

FY2025 Q1 Overview
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2025 Q1 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Presentation [PDF 1.9MB]
- Script (including Q&A) [PDF 12.3MB]
Mar 24,2025
Information Meeting on Lunsumio^®
Products / R&D
Show more

Overview of LUNSUMIO^® for Intravenous Infusion
Kenichi Aoki, Ph.D.,
NHL Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
A New Treatment Option for Third-line and Beyond for Relapsed or Refractory Follicular Lymphoma – Lunsumio –
Dai Maruyama, M.D., Ph.D.,
Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research
- Presentation [PDF 6.8MB]
- Script (including Q&A) [PDF 20.1MB]
Feb 26,2025
Tour of Manufacturing Building “FJ3” for Small and Mid-Size Molecule APIs at Fujieda Plant
Products / R&D
Show more

Establishing the World Class Manufacturing System for Small and Mid-Size Molecules to Drive the Realization of TOP I 2030
Shinya Takuma,
Vice President, Head of Manufacturing Technology Div., Chugai Pharmaceutical Co., Ltd.
Pharmaceutical Technology for Mid-Size Molecule Drug APIs
Dr. Kenji Maeda,
Head of API Process Development Dept., Pharmaceutical Technology Div., Chugai Pharmaceutical Co., Ltd.
Introduction of Fujieda Plant, Chugai Pharma Manufacturing Co., Ltd.
Kaichiro Koyama,
Head of Fujieda Plant, Chugai Pharma Manufacturing Co., Ltd.
- Presentation [PDF 5.6MB]
- Script (including Q&A) [PDF 9.0MB]
Jan 30,2025
Conference on FY 2024.12 Financial Results
Results
Show more

FY2024 Overview and FY2025 Forecast
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Dr. Michiaki Tanaka,
Head of R&D Portfolio Management Dept., Project & Lifecycle Management Unit
FY2024 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Presentation [PDF 2.3MB]
- Script (including Q&A) [PDF 22.6MB]

2024

Dec 17,2024
Chugai R&D Meeting
Products / R&D
Show more

Presence in the Oncology Area
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
Blood Cancer Pipeline
Dr. Misato Hashizume,
Franchise Lead for Hematological Malignancies
Giredestrant
Inavolisib
Yuji Habara,
Giredestrant & Inavolisib & HER2 Franchise Lifecycle Leader
Divarasib
Divarasib Lifecycle Leader
Avutometinib
Dr. Shunichiro Iwasawa,
Avutometinib Lifecycle Leader
- Presentation [PDF 7.0MB]
- Script (including Q&A) [PDF 8.3MB]
Nov 13,2024
Sustainability Meeting
Corporate
Show more

Chugai’s Value Creation
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
Overview of Material Issues Review
Yoshiyuki Yano,
Executive Vice President
Supervisory responsibility for Human Resource Management and ESG
Co-Creation of a Healthcare Ecosystem
Naoya Fujihara,
Vice President
In charge of External Affairs Dept.
Our Challenge for PHC Solutions
Tetsuya Yamaguchi,
Executive Vice President
Supervisory responsibility for PHC Solution, Partnering and Special Mission for CVF
- Presentation [PDF 2.5MB]
- Script (including Q&A) [PDF 16.9MB]
Oct 25,2024
Conference on FY2024.12 Q3 Financial Results
Results
Show more

FY2024 Q3 Overview
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2024 Q3 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Presentation [PDF 3.5MB]
- Script (including Q&A) [PDF 7.1MB]
Oct 01,2024
Chugai IR Day
Corporate
Show more

Dr. Osamu Okuda, President & CEO
Dr. Hitoshi Iikura, Director, Executive Vice President
Dr. Fumio Tateishi, Independent Outside Director
Hideo Teramoto, Independent Outside Director
- Summary [PDF 316KB]
Jul 25,2024
Conference on FY2024.12 Q2 Financial Results
Results
Show more

FY2024 Q2 Overview and Refinement of Five Reforms on “TOP I 2030”
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2024 Q2 Interim Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Presentation [PDF 1.9MB]
- Script (including Q&A) [PDF 16.2MB]
Jun 27,2024
Information Meeting on PiaSky^®
Products / R&D
Show more

Overview of PiaSky^® for Injection 340 mg
Kumi Miura,
PiaSky Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Clinical Significance of PiaSky^® in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Naoshi Obara, M.D., Ph.D.,
Professor, Department of Medical Sciences, Faculty of Medicine, University of Tsukuba
- Presentation [PDF 3.8MB]
- Script (including Q&A) [PDF 25.7MB]
Apr 24,2024
Conference on FY2024.12 Q1 Financial Results
Results
Show more

FY2024 Q1 Overview
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2024 Q1 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Presentation [PDF 1.8MB]
- Script (including Q&A) [PDF 11.0MB]
Feb 01,2024
Conference on FY 2023.12 Financial Results
Results
Show more

FY2023 Overview and FY2024 Forecast
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Foundation Medicine Unit
FY2023 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
- Presentation [PDF 3.2MB]
- Script (including Q&A) [PDF 6.6MB]

2023

Dec 12,2023
Chugai R&D Meeting
Products / R&D
Show more

Characteristics of Chugai’s Research to Early Development
Tomoyuki Igawa Ph.D., Associate Vice President, Head of Translational Research Div.
Chugai’s Mid-Size Molecule Drug Discovery
Hitoshi Iikura Ph.D., Vice President, Head of Research Div.
- Presentation [PDF 5.1MB]
- Script (including Q&A) [PDF 6.4MB]
Nov 30,2023
Information Meeting on PHESGO^®
Products / R&D
Show more

Overview of PHESGO^® Combination for Subcutaneous Injection MA/IN
Yuji Habara,
HER2 franchise Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Clinical Significance of PHESGO^® in the Treatment of HER2-Positive Breast Cancer
Naoki Hayashi, M.D., Ph.D.
Professor and Chairman, Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine
- Presentation [PDF 3.7MB]
- Script (including Q&A) [PDF 17.9MB]
Nov 20,2023
Sustainability Meeting
Corporate
Show more

Shared Value Creation Model for Chugai and Society
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Supervisory responsibility for Finance & Accounting, Corporate Communications and Procurement
Case Study: Collaboration with Patient Organizations
Hiroyuki Yamase,
Head of Public Affairs Group External Affairs Dept.
Sustainability and Risk Management
Case Study: Preparation of a Digital Compliance System
Junichi Ebihara,
Executive Vice President
Supervisory responsibility for Legal, Intellectual Property, General Affairs, Risk Management, Compliance and Quality & Regulatory Compliance
Human Capital and Innovation
Yoshiyuki Yano,
Executive Vice President
Supervisory responsibility for Human Resource Management and EHS
Case Study: Promote the Success of women
Kaeko Sato,
Head of Diversity Office Human Resources Management Dept.
- Presentation [PDF 3.0MB]
- Script (including Q&A) [PDF 22.3MB]
Oct 24,2023
Conference on FY2023.12 Q3 Financial Results
Results
Show more

FY2023 Q3 Overview
Dr. Osamu Okuda,
President & CEO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2023 Q3 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
- Presentation [PDF 2.3MB]
- Script (including Q&A) [PDF 4.6MB]
Sep 29,2023
Chugai DX Meeting
Corporate
Show more

Progress in CHUGAI DIGITAL
Satoko Shisai,
Executive Vice President, Head of Digital Transformation Unit
Three Initiatives to Strengthen the Digital Platform

Keisuke Ohara,
Head of IT Solution Dept.

Kazumitsu Kanatani,
Head of Digital Strategy Dept.

Status of Progress in the Insight Business
Dr. Nobuya Ishii,
Head of Science & Technology Intelligence Dept.
- Presentation [PDF 3.8MB]
- Script (including Q&A) [PDF 5.7MB]
Aug 29,2023
Chugai IR Day
Corporate
Show more

Dr. Osamu Okuda, President & CEO
Dr. Hisafumi Yamada, Director, Executive Vice President
Dr. Mariko Y Momoi, Independent Outside Director
- Summary [PDF 273KB]
Jul 27,2023
Conference on FY2023.12 Q2 Financial Results
Results
Show more

FY2023 Q2 Overview
Dr. Osamu Okuda,
President & CEO
FY2023 Q2 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.8MB]
- Script (including Q&A) [PDF 11.6MB]
Jul 18,2023
Chugai Life Science Park Yokohama Laboratory Tour
Products / R&D
Show more

Initiatives Underway at the New Research Facility Aimed at Creating Innovative New Drugs
Dr. Hitoshi Iikura, Vice President
Head of Research Division
Expansion of Drug Discovery Research that Fuses Dry and Wet Research
Dr. Atsushi Ohta,
Head of Modality Technology Research Department
Acceleration of Chugai Drug Discovery with 3D Structures Generated by Cryogenic Electron Microscopy (Cryo-EM)
Dr. Takuya Torizawa
Head of Protein Science Department
- Presentation [PDF 5.0MB]
- Script (including Q&A) [PDF 6.4MB]
Jun 30,2023
Company Briefing for Individual Investors (Antibody Engineering Technologies)
Products / R&D
Show more

Chugai Company Information Meeting
Dr. Osamu Okuda, President & CEO
Dr. Tomoyuki Igawa, Associate Vice President
Head of Translational Research Div.
- Presentation [PDF 2.6MB]
- Script (including Q&A) [PDF 4.4MB]
Apr 27,2023
Conference on FY 2023.12 Q1 Financial Results
Results
Show more

FY2023 Q1 Overview
Dr. Osamu Okuda,
President & CEO
FY2023 Q1 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.7MB]
- Script (including Q&A) [PDF 4.4MB]
Feb 02,2023
Conference on FY 2022.12 Financial Results
Results
Show more

FY2022 Overview and FY2023 Forecast
Dr. Osamu Okuda,
President & CEO
FY2022 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 3.1MB]
- Script (including Q&A) [PDF 6.7MB]

2022

Nov 08,2022
Chugai ESG Meeting
Corporate
Show more

Sustainability Management
Toshiaki Itagaki, Director, Executive Vice President & CFO
Chugai’s Governance and Issues Going Forward
Masayuki Oku, Independent Outside Director
Transformation Tasks in Materiality - Environment and Human Resources -
Yoshiyuki Yano, Executive Vice President, Head of Human Resources Management Dept.
Patient-Centric Business Activities - Medical Affairs -
Dr. Kaori Ouchi, Vice President, Head of Medical Affairs Div.
- Presentation [PDF 2.0MB]
- Script (including Q&A) [PDF 19.7MB]
Oct 24,2022
Conference on FY2022.12 3Q Financial Results
Results
Show more

FY2022 3Q Overview
Dr. Osamu Okuda,
President & CEO
FY2022 3Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.8MB]
- Script (including Q&A) [PDF 11.4MB]
Sep 01,2022
Chugai IR Day
Corporate
Show more

Dr. Osamu Okuda, President & CEO
Dr. Hisafumi Yamada, Director, Executive Vice President
Toshiaki Itagaki, Director, Executive Vice President & CFO
Tetsuya Yamaguchi, Executive Vice President, Head of Project & Lifecycle Management Unit
Junichi Ebihara, Executive Vice President
Shinji Hidaka, Executive Vice President, Head of Marketing & Sales Division
Yoshiyuki Yano, Executive Vice President, Head of Human Resources Management Dept.
Satoko Shisai, Executive Vice President, Head of Digital Transformation Unit
- Summary [PDF 370KB]
Jul 21,2022
Conference on FY 2022.12 2Q Financial Results
Results
Show more

FY2022 2Q Overview
Dr. Osamu Okuda,
President & CEO
FY2022 2Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.7MB]
- Script (including Q&A) [PDF 5.3MB]
Jun 24,2022
Information Meeting on Vabysmo^®
Products / R&D
Show more

Overview of Vabysmo^® Solution for Intravitreal Injection 120 mg/mL
Masashi Kishida, Ph.D.,
Vabysmo Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Clinical Significance of Vabysmo^®
Tomohiro Iida, M.D., Ph.D.,
Professor & Chairman, Department of Ophthalmology, Tokyo Women’s Medical University
- Presentation [PDF 3.8MB]
- Script (including Q&A) [PDF 48.6MB]
Apr 25,2022
1Q Results (Jan - Mar 2022) Conference Call
Results
Show more

FY2022 1Q Overview
Dr. Osamu Okuda,
President & CEO
FY2022 1Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Director, Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.5MB]
- Script (including Q&A) [PDF 3.6MB]
Feb 03,2022
Conference on FY2021.12 Financial Results
Results
Show more

FY2021 Overview and FY2022 Forecast
Dr. Osamu Okuda,
President & CEO
FY2021 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Executive Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 3.1MB]
- Script (including Q&A) [PDF 13.2MB]

2021

Dec 13,2021
Chugai R&D Meeting
Products / R&D
Show more

Chugai’s Research Policy/Chugai’s Mid-Size Molecule Drug Discovery
Hitoshi Iikura Ph.D., Head of Research Div.
Update on Antibody Engineering Technologies
Tomoyuki Igawa Ph.D., Head of Translational Research Div.
- Presentation [PDF 4.7MB]
- Script (including Q&A) [PDF 2.6MB]
Nov 16,2021
Chugai ESG Meeting
Corporate
Show more

Sustainability Management
Motoo Ueno, Representative Director & Deputy Chairman
Materiality and ESG Ratings
Toshiaki Itagaki, Executive Vice President & CFO
ESG in the Context of Growth Strategy Drug Development in Pursuit of Sustainable Healthcare
Tsukasa Kusano, Vice President, Head of Clinical Development Div.
ESG in the Context of Growth Strategy Global Environmental Initiatives (Pharmaceutical Technology)
Shigehiro Yamada, Ph. D., Head of Sustainability Dept.
- Presentation [PDF 2.0MB]
- Script (including Q&A) [PDF 6.4MB]
Oct 22,2021
3Q Results (Jan - Sep 2021) Conference Call
Results
Show more

FY2021 3Q Overview
Dr. Osamu Okuda,
President & CEO
FY2021 3Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Senior Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 2.2MB]
- Script (including Q&A) [PDF 4.4MB]
- Webcast (including Q&A)(END)
Sep 27,2021
Information Meeting on Evrysdi^®️
Products / R&D
Show more

Overview of Evrysdi^®
Hideto Kodaira,
Evrysdi Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Evrysdi^®, a New Treatment Option for Spinal Muscular Atrophy (SMA): The First Oral SMA Drug
Kayoko Saito, MD, PhD,
Professor of Special Appointment, Institute of Medical Genetics, Tokyo Women’s Medical University
- Presentation [PDF 3.5MB]
- Script (including Q&A) [PDF 9.8MB]
Sep 09,2021
Information Meeting on FoundationOne^® Liquid CDx
Products / R&D
Show more

Product Overview
Satoru Ito,
Lifecycle Leader, Foundation Medicine Unit, Chugai Pharmaceutical Co., Ltd.
Current Status of Cancer Genomic Medicine in Japan and Expectations for FoundationOne^® Liquid CDx Cancer Genomic Profile
Takayuki YOSHINO, MD, PhD,
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East (NCCE), Japan
- Presentation [PDF 2.2MB]
- Script (including Q&A) [PDF 9.3MB]
Sep 03,2021
Chugai CEO Meeting
Corporate
Show more

Dr.Osamu Okuda, President & CEO
- Summary [PDF 359KB]
Aug 26,2021
Information Meeting on RONAPREVE^™
Products / R&D
Show more

Striving to Develop Therapeutic Drugs for COVID-19
Dr.Osamu Okuda,
President & CEO, Chugai Pharmaceutical Co., Ltd.
Product Overview of RONAPREVE^™ Intravenous Infusion Set
Satoshi Aida,
Ph.D., RONAPREVE Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Confronting COVID-19
Prof. Kazuhiro Tateda M.D., Ph.D.,
Department of Microbiology and Infectious Disease, Toho University School of Medicine
- Presentation [PDF 7.7MB]
- Script (including Q&A) [PDF 5.2MB]
- Webcast (including Q&A)(END)
Jul 26,2021
2Q Results (Jan - Jun 2021) Conference Call
Results
Show more

FY2021 2Q Overview
Dr. Osamu Okuda,
President & CEO
FY2021 2Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Senior Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.9MB]
- Script (including Q&A) [PDF 4.8MB]
- Webcast (including Q&A)(END)
Jun 03,2021
Information Meeting on Polivy^®
Products / R&D
Show more

Polivy^® Intravenous Infusion 30mg/140mg
Dr. Takaki Koga,
POLIVY^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Treatment Options for Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Koji Izutsu, M.D., Ph.D.,
Department of Hematology, National Cancer Center Hospital
- Presentation [PDF 2.2MB]
- Script (including Q&A) [PDF 10.9MB]
- Webcast (including Q&A)(END)
Apr 22,2021
1Q Results (Jan - Mar 2021) Conference Call
Results
Show more

FY2021 1Q Overview
Dr. Osamu Okuda,
President & CEO
FY2021 1Q Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Senior Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.3MB]
- Script (including Q&A) [PDF 2.6MB]
- Webcast (including Q&A)(END)
Feb 04,2021
Conference on FY2020.12 Financial Results
Results
Show more

Review of 2020 and General Overview of IBI 21
Tatsuro Kosaka,
Chairman & CEO
FY2020 Consolidated Financial Overview (Core)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Tetsuya Yamaguchi,
Senior Vice President, Head of Project & Lifecycle Management Unit
New Growth Strategy for 2030
Dr. Osamu Okuda,
President & COO
- Presentation [PDF 3.3MB]
- Webcast (including Q&A)(END)

2020

Dec 02,2020
Chugai Digital Strategy Meeting
Corporate
Show more

CHUGAI DIGITAL VISION 2030
Satoko Shisai, Vice President, Head of Digital & IT Supervisory Div.
Innovation in the Drug Discovery Process Using AI
Dr. Hiroyuki Tsunoda, Head of Discovery Technology Dept., Research Div.
Utilization of Real World Data
Dr. Nobuya Ishii, Head of Science & Technology Intelligence Dept., Project & Lifecycle Management Unit
Digital Marketing Strategy
Takato Shimauchi, Head of Customer Solution Dept., Marketing & Sales Div.
- Presentation [PDF 6.7MB]
- Webcast(END)
Oct 22,2020
3Q Results (Jan - Sep 2020) Conference Call
Results
Show more

FY2020 3Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Head of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 903KB]
- Webcast(END)
Sep 29,2020
Chugai ESG Meeting
Corporate
Show more

Progress in sustainability-oriented management and strategies
Motoo Ueno, Representative Director & Deputy Chairman
Deep-dive theme 1: Sustainability-related Indicators
Toshiaki Itagaki, Executive Vice President & CFO
Deep-dive theme 2: Long-term Planning
Shigehiro Yamada, Ph.D., Head of Sustainability Dept.
Deep-dive theme 3: Examples of Shared Value Creation
Keiji Kono, Senior Vice President,
In charge of External Affairs Dept. and Global Health Policy
- Presentation [PDF 1.1MB]
- Webcast(END)
Sep 14,2020
Information Meeting on ENSPRYNG^® Subcutaneous Injection
Products / R&D
Show more

Product Overview of ENSPRYNG^® Subcutaneous Injection 120 mg Syringe
Katsuhiro Hara,
ENSPRYNG^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Current Status of the Treatment for Neuromyelitis Optica Spectrum Disorders (NMOSD) and Expectations for ENSPRYNG
Prof. Kazuo Fujihara, M.D.
Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine
- Presentation [PDF 4.6MB]
- Webcast(END)
Sep 04,2020
Chugai CEO Meeting
Corporate
Show more

Tatsuro Kosaka, Chairman and CEO
Dr. Minoru Watanabe, Vice President, Head of Project & Lifecycle Management Unit
- Summary [PDF 218KB]
Jul 27,2020
2Q Results (Jan - Jun 2020) Conference Call
Results
Show more

Aiming to Achieve the Mid-term Business Plan “IBI 21”
- FY2020 Half Year Results -
Tatsuro Kosaka,
Chairman and CEO
FY2020 2Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Minoru Watanabe,
Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 936KB]
- Webcast(END)
Apr 23,2020
1Q Results (Jan - Mar 2020) Conference Call
Results
Show more

FY2020 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Head of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 1.1MB]
- Webcast(END)
Jan 31,2020
Investor conference on FY 2019.12 Financial Results
Results
Show more

Mid-term Business Plan “IBI 21”
- 2019 Results and 2020 Strategic Policies -
Tatsuro Kosaka,
President and CEO
FY2019 Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Yasushi Ito,
Executive Vice President and Co-Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.8MB]
- Webcast(END)

2019

Dec 09,2019
Information Meeting on Antibody Engineering Technologies
Products / R&D
Show more

Chugai’s Strategy for Drug Discovery Research
Junichi Nezu, PhD,
General Manager of Research Division
Chugai Pharmaceutical Co., Ltd.
Chugai’s Antibody Engineering Technologies for Innovative Drug Discovery
Tomoyuki Igawa, PhD,
CEO and Research Head, Chugai Pharmabody Research Pte. Ltd.
Oct 24,2019
3Q Results (Jan - Sep 2019) Conference Call
Results
Show more

FY2019 3Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President, CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Department Manager of R&D Portfolio Management Dept
- Presentation [PDF 887KB]
- Webcast(END)
Sep 05,2019
Information Meeting on Rozlytrek^®
Products / R&D
Show more

Product Overview of Rozlytrek^®
Yoshito Nakanishi,
Rozlytrek^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
From organ specific to gene specific cancer treatment
- Expectations on ROZLYTREK for NTRK Fusion-Positive Solid Tumors -
Takayuki Yoshino, MD, PhD
Director, Department of Gastroenterology and Gastrointestinal Oncology,
National Cancer Center Hospital East (NCCE), Japan
Co-principal investigator, GI-SCREEN-Japan
- Presentation [PDF 5.0MB]
- Webcast(END)
Sep 03,2019
Chugai CEO Meeting
Corporate
Show more

Tatsuro Kosaka, President and CEO
Yasushi Ito, Executive Vice President, Co-Head of Project & Lifecycle Management Unit
- Presentation [PDF 239KB]
Jul 26,2019
Investor Conference on FY2019 2Q Financial Results
Results
Show more

Aiming to Achieve the Mid-term Business Plan “IBI 21”
- FY2019 Half Year Results -
Tatsuro Kosaka,
President and CEO
FY2019 2Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Yasushi Ito,
Executive Vice President and Co-Head of Project & Lifecycle Management Unit
- Presentation [PDF 969KB]
- Webcast(END)
Jul 04,2019
Information Meeting on FoudationOne^® CDx
Products / R&D
Show more

1. FoundationOne^® CDx Cancer Genomic Profile Product Overview
Kosuke Iijima, Department Manager of Foundation Medicine Business Dept., Foundation Medicine Unit
2. Cancer Genomic Medicine
- Clinical Implementation and Challenges -
Prof. Muto Manabu, Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University
- Presentation [PDF 6.5MB]
- Webcast(END)
Jun 18,2019
ESG Meeting
Corporate
Show more

Motoo Ueno, Representative Director, Deputy Chairman
- Presentation [PDF 2.0MB]
- Webcast(END)
Apr 24,2019
1Q Results (Jan - Mar 2019) Conference Call
Results Products / R&D
Show more

FY2019 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Department Manager of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 1.1MB]
- Webcast(END)
Feb 01,2019
Investor conference on FY 2018.12 Financial Results
Results
Show more

New Mid-term Business Plan “IBI 21”
Tatsuro Kosaka,
President and CEO
FY2018 Consolidated Financial Overview (IFRS based)
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Yasushi Ito,
Executive Vice President and Co-Head of Project & Lifecycle Management Unit
- Presentation [PDF 2.3MB]
- Webcast(END)

2018

Nov 07,2018
Information Meeting on GAZYVA^®
Products / R&D
Show more

1. Product Overview of GAZYVA^® Intravenous Infusion 1000 mg
Naoko Oya, GAZYVA^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
2. Pathology of Follicular Lymphoma and Clinical Trial Results of obinutuzumab
Kiyohiko Hatake, M.D., Ph.D.
Deputy Director, Head of the Malignant Tumor and Hematologic Tumor Center at the International University of Health and Welfare, Mita Hospital, Japan
- Presentation [PDF 2.1MB]
- Webcast(END)
Oct 24,2018
3Q Results (Jan - Sep 2018) Conference Call
Results Products / R&D
Show more

FY2018 3Q Consolidated Financial Overview (IFRS based)
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Department Manager of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 589KB]
- Webcast(END)
Aug 28,2018
Chugai CEO Meeting
Corporate
Show more

Tatsuro Kosaka, President and CEO
- Presentation [PDF 232KB]
Jul 27,2018
Investor Conference on FY2018 2Q Financial Results
Results Products / R&D
Show more

Aiming to Achieve Mid-term Business Plan “IBI 18”
- FY2018 Half Year Results -
Tatsuro Kosaka,
President and CEO
FY2018 2Q Consolidated Financial Overview (IFRS based)
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Yasushi Ito,
Executive Vice President and Co-Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.0MB]
- Webcast(END)
Jun 01,2018
Information Meeting on HEMLIBRA^®
Products / R&D
Show more

1. HEMLIBRA^® Subcutaneous Injection Product Overview
Hiroshi Motegi, HEMLIBRA^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
2. Current Status of Hemophilia Treatment and Expectations for HEMLIBRA^®
Prof. Midori Shima, M.D., Ph.D.
Department of Pediatrics, Nara Medical University
- Presentation [PDF 3.3MB]
- Webcast(END)
May 22,2018
R&D Conference Call (WFH 2018)
Products / R&D
Show more

R&D Conference Call (WFH 2018)
Professor Midori Shima, M.D., Ph.D.
Department of Pediatrics, Nara Medical University
Tatsuro Kosaka, President & CEO, Chugai Pharmaceutical Co., Ltd.
- Presentation [PDF 961KB]
- Webcast(END)
Apr 24,2018
1Q Results (Jan-Mar 2018) Conference Call
Results Products / R&D
Show more

FY2018 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Executive Vice President & CFO
Overview of Development Pipeline
Dr. Minoru Hirose,
Department Manager of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 679KB]
- Webcast(END)
Apr 12,2018
Information Meeting on TECENTRIQ^®
Products / R&D
Show more

1. TECENTRIQ^® Intravenous Infusion 1200mg Product Overview
Mikio Sakai, TECENTRIQ^® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
2. The Anti-PD-L1 Antibody Tecentriq^® Mode of Action and Future Outlook
Hiroyoshi Nishikawa, M.D., Ph.D.
Department of Immunology, Nagoya University Graduate School of Medicine
Exploratory Oncology Research & Clinical Trial Center, Research Institute, National Cancer Center
3. Treatment Overview of Non-Small Cell Lung Cancer and Clinical Trials for Tecentriq^®
Yuichiro Ohe, M.D.
Deputy Director, Chief,
Division of Thoracic Oncology
National Cancer Center Hospital, Japan
- Presentation [PDF 9.6MB]
- Webcast(END)
Feb 02,2018
Investor Conference on FY 2017.12 Financial Results
Results
Show more

Aiming to Achieve Mid-Term Business Plan “IBI 18”
-2017 Results and 2018 Outlook-
Tatsuro Kosaka, President, COO
FY2017 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President, CFO
Overview of Development Pipeline
Yasushi Ito, Senior Vice President,
Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.5MB]
- Webcast(END)

2017

Oct 25,2017
3Q Results (Jan - Sep 2017) Conference Call
Results
Show more

FY2017 3Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President, General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Minoru Hirose,
Department Manager of R&D Portfolio Management Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 555KB]
- Webcast(END)
Jul 28,2017
Investor Conference on FY2017 2Q Financial Results
Results
Show more

FY2017 2Q Consolidated Financial Overview
Yoshio Itaya,
Executive Vice President, CFO
Overview of Development Pipeline
Yasushi Ito,
Senior Vice President, Head of Project & Lifecycle Management Unit
- Presentation [PDF 1,016KB]
- Webcast(END)
Jul 11,2017
R&D Conference Call (ISTH 2017)
Products / R&D
Show more

R&D Conference Call (ISTH 2017)
Professor Midori Shima, M.D., PhD.
Department of Pediatrics Nara Medical College
Dr. Hisanori Takanashi, Vice President, General Manager of Clinical Development Div.
- Presentation [PDF 446KB]
- Webcast(END)
Jun 29,2017
R&D Conference Call
Products / R&D
Show more

R&D Conference Call
Megumi Uzu,
Department Manager of Oncology Lifecycle Management Dept.
- Presentation [PDF 1.2MB]
- Webcast(END)
Apr 25,2017
1Q Results (Jan-Mar 2017) Conference Call
Results
Show more

FY2017 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President, General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Shinichiro Iida,
Department Manager of Business Assessment Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 485KB]
- Webcast(END)
Feb 02,2017
Information Meeting on FY 2016.12 Financial Results
Results
Show more

Mid-Term Business Plan “IBI 18”
-2016 Results and 2017 Outlook-
Tatsuro Kosaka, President, COO
FY2016 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President, CFO
Overview of Development Pipeline
Yasushi Ito, Senior Vice President,
Head of Project & Lifecycle Management Unit
Reorganization to Provide a New Solution
Susumu Kato, Senior Vice President,
General Manager of Marketing & Sales Div.
- Presentation [PDF 896KB]
- Webcast(END)

2016

Dec 14,2016
CEO Meeting
Corporate
Show more

Challenges Facing Japan’s Pharmaceutical Industry and Orientation of the Solution
Chairman and CEO　Osamu Nagayama
- Presentation [PDF 1.2MB]
- Webcast(END)
Oct 25,2016
3Q Results (Jan - Sep 2016) Conference Call
Results
Show more

FY2016 3Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Shinichiro Iida,
Department Manager of Business Assessment Dept.,
Project & Lifecycle Management Unit
- Presentation [PDF 457KB]
- Webcast(END)
Jul 22,2016
Information Meeting on FY2016 2Q Financial Results
Results
Show more

FY2016 2Q Consolidated Financial Overview
Yoshio Itaya,
Executive Vice President CFO
Overview of Development Pipeline
Minoru Watanabe,
Associate Vice President
Deputy General Manager of Research Division
- Presentation [PDF 1.1MB]
- Webcast(END)
Jul 04,2016
R&D Conference Call
Products / R&D
Show more

R&D Conference Call
Megumi Uzu,
Department Manager of Oncology Lifecycle Management Dept.
- Presentation [PDF 618KB]
- Webcast(END)
Apr 22,2016
1Q Results (Jan-Mar 2016) Conference Call
Results
Show more

FY2016 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Minoru Watanabe,
Associate Vice President
Deputy Head of Project & Lifecycle Management Unit
Department Manager of R&D Portfolio Management Dept.
- Presentation [PDF 382KB]
- Webcast(END)
Apr 05,2016
Information Meeting on Bonviva^®
Products / R&D
Show more

1. Product Overview of Bonviva^® Tablet
Takeshi Sakaguchi
Bonviva^® Product Manager
Chugai Pharmaceutical Co., Ltd.
2. Bonviva^® Tablet: Clinical Utility and Our Expectation
Hiroshi Hagino, M.D., Ph.D., Professor
School of Health Science
Tottori University Faculty of Medicine, Japan
- Presentation [PDF 3.0MB]
- Webcast(END)
Jan 29,2016
Information Meeting on FY 2015.12 Financial Results
Results
Show more

New Mid-Term Business Plan "IBI 18"
Tatsuro Kosaka, President, COO
FY2015 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President, CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President
- Presentation [PDF 1.8MB]
- Webcast(END)

2015

Oct 22,2015
3Q Results (Jan 15 - Sep 15) Conference Call
Results
Show more

FY2015 3Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Minoru Watanabe,
Associate Vice President
Deputy Head of Project & Lifecycle Management Unit
Department Manager of R&D Portfolio Management Dept.
- Presentation [PDF 414KB]
- Webcast(END)
Jul 24,2015
Information Meeting on FY 2015.12 2Q Financial Results
Results
Show more

FY2015 2Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President
- Presentation [PDF 611KB]
- Webcast(END)
Apr 22,2015
1Q Results (Jan 15 - Mar 15) Conference Call
Results
Show more

FY2015 1Q Consolidated Financial Overview
Toshiaki Itagaki,
Vice President General Manager of Finance & Accounting Dept.
Overview of Development Pipeline
Minoru Watanabe,
Associate Vice President
Deputy Head of Project & Lifecycle Management Unit
Department Manager of R&D Portfolio Management Dept.
- Presentation [PDF 333KB]
- Webcast(END)
Apr 02,2015
Information Meeting on ZELBORAF^®
Products / R&D
Show more

1. Overview of ZELBORAF^®
Takahiro Mizui
ZELBORAF^® Lifecycle Leader
CHUGAI PHARMACEUTICAL CO., LTD.
2. cobas^® BRAF V600 Mutation Test
Toru Ogawa
Manager, Molecular Diagnostics
Roche Diagnostics K.K.
3. ZELBORAF^® tablet Postmarketing safety measures
Shin Yoshida
Pharmacovigilance Department
CHUGAI PHARMACEUTICAL CO., LTD.
4．Overview of melanoma and clinical trials of vemurafenib
Naoya Yamazaki, M.D., Ph.D.
Chief, Dept. of Dermatologic Oncology
National Cancer Center Hospital, Japan
- Presentation [PDF 2.1MB]
- Webcast(END)
Jan 29,2015
Information Meeting on FY 2014.12 Financial Results
Results
Show more

Aiming to Become a Top Pharmaceutical Company
Tatsuro Kosaka, President, COO
FY2014 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President, CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President,
Head of Project & Lifecycle Management Unit
- Presentation [PDF 746KB]
- Webcast(END)

2014

Dec 16,2014
Information Meeting on Research & Development
Products / R&D
Show more

Development Portfolio of Chugai Pharmaceutical
Yutaka Tanaka, Executive Vice President and Head of Project & Lifecycle Management Unit
Overview of HER2 Franchise
Tsuyoshi Takasuka, Oncology Lifecycle Management Dept.
Overview of Anti-PDL1 Antibody RG7446 (MPDL3280A)
Mikio Sakai, Oncology Lifecycle Management Dept.
Overview of Bispecific Antibody ACE910
Hiroshi Motegi, Primary Lifecycle Management Dept.
- Presentation [PDF 1.2MB]
- Webcast(END)
Oct 24,2014
3Q Results (Jan 14 - Sep 14) Conference Call
Results
Show more

FY2014 3Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President and Head of Project & Lifecycle Management Unit
- Presentation [PDF 475KB]
- Webcast(END)
Aug 21,2014
Information Meeting on ALECENSA^®
Products / R&D
Show more

Overview of ALECENSA^®
Megumi Uzu,
ALECENSA Lifecycle Leader
Chugai Pharmaceutical Co., Ltd.
Overview of ALK-Rearranged Non-Small Cell Lung Cancer and Clinical Trial of Alectinib (AF-001JP)
Yuichiro Ohe, M.D.
Deputy Director, Chief,
Division of Thoracic Oncology
National Cancer Center Hospital, Japan
ALECENSA^® Postmarketing Safety Measures
Chiaki Iiyama,
Pharmacovigilance Dept.
Chugai Pharmaceutical Co., Ltd.
- Presentation [PDF 2.6MB]
- Webcast(END)
Jul 25,2014
Information Meeting on FY 2014.12 2Q Financial Results
Results
Show more

FY2014 2Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President Head of Project & Lifecycle Management Unit
- Presentation [PDF 706KB]
- Webcast(END)
Apr 24,2014
1Q Results (Jan 14 - Mar 14) Conference Call
Results
Show more

FY2014 1Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Executive Vice President Head of Project & Lifecycle Management Unit
- Presentation [PDF 440KB]
- Webcast(END)
Jan 31,2014
Information Meeting on FY 2013.12 Financial Results
Results
Show more

Aiming to Become a Top Pharmaceutical Company
Tatsuro Kosaka, President & COO
FY2013 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.6MB]
- Webcast(END)

2013

Oct 25,2013
3Q Results (Jan 13 - Sep 13) Conference Call
Results
Show more

FY2013 3Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President Head of Project & Lifecycle Management Unit
- Presentation [PDF 533KB]
- Webcast(END)
Aug 30,2013
Information Meeting on Bonviva^®
Products / R&D
Show more

Product Overview of Bonviva^®
Yoshiomi Morishita
Bonviva Product Manager
Chugai Pharmaceutical Co., Ltd.
Clinical Usefulness and Our Expectation of Bonviva^®
Masako Ito, Professor, M.D.
Medical Work-Life-Balance Center
Nagasaki University Hospital, Japan
- Presentation [PDF 3.1MB]
- Webcast(END)
Jul 26,2013
Information Meeting on FY 2013.12 2Q Financial Results
Results
Show more

FY2013 2Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.0MB]
- Webcast(END)
Apr 25,2013
1Q Results (Jan 13 - Mar 13) Conference Call
Results
Show more

FY2013 1Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, Project Planning & Coordination Dept.
- Presentation [PDF 485KB]
- Webcast(END)
Jan 31,2013
Information Meeting on FY 2012.12 Financial Results
Results
Show more

New Mid-Term Business Plan “ACCEL 15”
Tatsuro Kosaka, President & COO
FY2012 Consolidated Financial Overview
Yoshio Itaya, Executive Vice President CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Project & Lifecycle Management Unit
- Presentation [PDF 1.8MB]
- Webcast(END)

2012

Dec 18,2012
Information Meeting on Antibody Engineering Technologies
Products / R&D
Show more

1. Proprietary Innovative Antibody Engineering Technologies in Chugai Pharmaceutical
Hisafumi Okabe, Vice President General Manager of Research Division
2. Technology Introduction of SMART-Ig and its Application to Actemra^®
Tomoyuki Igawa, Research Division, Discovery Research Dept.
3. Introduction of ART-Ig and application to hemophilia A treatment
Kunihiro Hattori, Research Division, Department Manager, Discovery Research Dept.
4. Technology Introduction of ART-Fc, TRAB, TwoB-Ig, ACT-Ig and its Application
Hiroyuki Tsunoda, Research Division, Discovery Research Dept.
- Presentation [PDF 7.3MB]
Dec 17,2012
Financial Reporting Based on IFRS Conference Call
Corporate
Show more

Financial Reporting Based on IFRS Conference Call
Yoshio Itaya, Executive Vice President CFO
- Presentation [PDF 423KB]
- Webcast(END)
Nov 16,2012
Information Meeting on Establishing Stable Cell Lines of Cancer Stem Cell
Products / R&D
Show more

Chugai Succeeds in Establishing Stable Cell
Lines of Cancer Stem Cell for the First Time
- A Step Forward in Elucidating the Mechanisms of Recurrence / Metastasis and Drug Resistance of Cancer and in the Development of a New Therapeutic Agent -
Research Division Masami Suzuki
- Presentation [PDF 2.9MB]
Oct 23,2012
3Q Results (Jan 12 - Sep 12) Conference Call
Results
Show more

FY2012 3Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, R&D Portfolio Management Dept.
- Presentation [PDF 2.5MB]
Jul 27,2012
Information Meeting on FY 2012.12 2Q Financial Results
Results
Show more

FY2012 2Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Project & Lifecycle Management Unit
- Presentation [PDF 547KB]
Apr 24,2012
1Q Results (Jan 12 - Mar 12) Conference Call
Results
Show more

FY2012 1Q Consolidated Financial Overview
Yoshio Itaya, Executive Vice President and CFO
Major Product Update
Masaaki Tohaya, Senior Vice President, General Manager of Sales Div.
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, R&D Portfolio Management Dept.
- Presentation [PDF 284KB]
Feb 02,2012
Information Meeting on FY 2011.12 Financial Results
Results
Show more

Aiming to Become a Top Japanese Pharmaceutical Company
- 2011 Results & 2012 Outlook -
Osamu Nagayama, President and CEO
FY2011 Consolidated Financial Overview
Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Lifecycle Management & Marketing Unit
- Presentation [PDF 748KB]

2011

Oct 28,2011
Chugai-RDKK PHC Seminar
Products / R&D
Show more

1. Personalized Healthcare (PHC) Approach in Chugai
Yutaka Tanaka, Senior Vice President, Head of Lifecycle Management & Marketing Unit, CHUGAI PHARMACEUTICAL CO., LTD.
2. Role of Clinical Diagnostics for The Personalized Healthcare (PHC)
Yoshiaki Tazawa, Lifecycle Management of Molecular Diagnostics, Roche Diagnostics K.K.
3. R&D Portfolio based on PHC Approach in Chugai
Hisanori Takanashi, Department Manager, R&D Portfolio Management Dept., CHUGAI PHARMACEUTICAL CO., LTD.
- Presentation [PDF 4.5MB]
Oct 21,2011
3Q Results (Jan 11 - Sep 11) Conference Call
Results
Show more

FY2011 3Q Consolidated Financial Overview
Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, R&D Portfolio Management Dept.
- Presentation [PDF 337KB]
Jul 22,2011
Information Meeting on FY 2011.12 2Q Financial Results
Results
Show more

FY2011 2Q Consolidated Financial Overview
Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Lifecycle Management & Marketing Unit
- Presentation [PDF 488KB]
Apr 21,2011
1Q Results (Jan 11 - Mar 11) Conference Call
Results
Show more

FY2011 1Q Consolidated Financial Overview
Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, R&D Portfolio Management Dept.
- Presentation [PDF 261KB]
Feb 03,2011
Information Meeting on FY 2010.12 Financial Results
Results
Show more

Aiming to Become a Top Japanese Pharmaceutical Company
- Review of 2010 and Plans for 2011 -
Osamu Nagayama, President and CEO
FY2010 Consolidated Financial Overview
Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline
Yutaka Tanaka, Senior Vice President,
Head of Lifecycle Management & Marketing Unit
- Presentation [PDF 685KB]

2010

Oct 22,2010
3Q Results (Jan 10 - Sep 10) Conference Call
Results
Show more

FY2010 3Q Consolidated Financial Overview
Executive Vice President and CFO, Ryuzo Kodama
Overview of Development Pipeline
Senior Vice President, Head of Portfolio Management Unit, Yutaka Tanaka
- Presentation [PDF 401KB]
Oct 08,2010
Information Meeting
Corporate
Show more

Roche: adapting to the changing environment
Severin Schwan, CEO, Roche Group
Aiming to Become a Top Japanese Pharmaceutical Company - Advancing into the Next Stage -
Osamu Nagayama, President and CEO, Chugai Pharmaceutical Co., Ltd.
- Roche: adapting to the changing environment [PDF 758KB]
- Aiming to Become a Top Japanese Pharmaceutical Company ～Advancing into the Next Stage〜 [PDF 1.9MB]
Sep 29,2010
Deutsche Bank Conference
Conference
Show more

Deutsche Bank Conference
Ryuzo Kodama, Executive Vice President and CFO
- Presentation [PDF 282KB]
Sep 08,2010
Information Meeting on Actemra
Products / R&D
Show more

Actemra Product Overview
Katsunori Yoshizawa, Actemra Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Removal of Conditions on Approval of Actemra for Intravenous Infusion with All Patients Surveillance
Shunji Yokoyama, Pharmacovigilance Manager, Chugai Pharmaceutical Co., Ltd.
Actemra Results of All Patients Surveillance and Its Position in RA Treatment in Japan
Tsutomu Takeuchi, M.D. Ph.D., Division of Rheumatology, School of Medicine, Keio University
- Presentation [PDF 1.0MB]
Jul 23,2010
Information Meeting on FY 2010.12 2Q Financial Results
Results
Show more

Aiming to Become a Top Japanese Pharmaceutical Company
Review of Half Year 2010
Osamu Nagayama, President and CEO
FY2010 2Q Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
Overview of Development Pipeline
Tatsuro Kosaka, Executive Vice President,
Head of Lifecycle Management Marketing Unit.
- Presentation [PDF 448KB]
Apr 23,2010
1Q Results (Jan 10 - Mar 10) Conference Call
Results
Show more

FY2010 1Q Consolidated Financial Overview
Yoshio Itaya, Senior Vice President,
General Manager of Finance Supervisory Div. and General Manager of Finance & Accounting Dept.
Overview of R&D Activities
Hisanori Takanashi, Department Manager,
Project Management Dept.
- Presentation [PDF 307KB]
Feb 04,2010
Information Meeting on FY 2009.12 Financial Results
Results
Show more

Aiming to Become a Top Japanese Pharmaceutical Company
- Review of 2009 and Plans for 2010 -
Osamu Nagayama, President and CEO
FY2009 Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
Overview of R&D Activities
Yutaka Tanaka, Senior Vice President,
Head of Portfolio Management Unit
- Presentation [PDF 716KB]

2009

Dec 07,2009
Information Meeting on Diabetes Products
Products / R&D
Show more

Overview of Chugai Diabetes
Hisanori Takanashi, Department Manager, Project Management Dept.
Overview of taspoglutide
Takaki Koga, Project Management Dept.
Overview of CSG452
Sachiya Ikeda, Project Management Dept.
- Presentation [PDF 1.0MB]
Dec 01,2009
Nomura Investment Forum 2009
Conference
Show more

Nomura Investment Forum 2009
Osamu Nagayama, President and CEO
- Presentation [PDF 377KB]
Oct 27,2009
3Q Results (Jan 09 - Sep 09) Conference Call
Results
Show more

FY2009 3Q Consolidated Financial Overview
Toshiaki Itagaki, General Manager, Finance & Accounting Dept.
Overview of Development Pipeline
Hisanori Takanashi, Department Manager, Project Management Dept.
- Presentation [PDF 329KB]
Sep 30,2009
Deutsche Bank Conference
Conference
Show more

Deutsche Bank Conference
Osamu Nagayama, President and CEO
- Presentation [PDF 388KB]
Aug 26,2009
Tour of Utsunomiya Plant
Products / R&D
Show more

Observation on Follow-on Biologics / Biosimilars
Group Manager, External Affairs Dept.
Junichi Matsuzaki, Ph. D.
- Presentation [PDF 1.3MB]
Jul 24,2009
Information Meeting on FY 2009.12 2Q Financial Results
Results
Show more

1)FY2009 2Q Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
2)Overview of Development Pipeline
Tatsuro Kosaka, Senior Vice President,
Head of Lifecycle Management Marketing Unit.
- FY2009 2Q Consolidated Financial Overview [PDF 214KB]
- Overview of Development Pipeline [PDF 187KB]
Apr 24,2009
1Q Results (Jan 09 - Mar 09) Conference Call
Results
Show more

FY2009 1Q Consolidated Financial Overview
Toshiaki Itagaki, General Manager, Finance & Accounting Dept.
Overview of R&D Activities
Hisanori Takanashi, Department Manager, Project Management Dept.
- Presentation [PDF 298KB]
Mar 27,2009
Information Meeting
Corporate
Show more

1)Aiming to Become a Top Japanese Pharmaceutical Company with Global-Level Capabilities
Osamu Nagayama, President and CEO
- Presentation [PDF 1.7MB]
Feb 05,2009
Information Meeting on FY 2008.12 Financial Results
Results
Show more

1)FY2008 Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
2)Overview of Development Pipeline
Tatsuro Kosaka, Senior Vice President,
Head of Lifecycle Management Marketing Unit.
- FY2008 Consolidated Financial Overview [PDF 194KB]
- Overview of Development Pipeline [PDF 138KB]

2008

Oct 21,2008
3Q Results (Jan 08 - Sep 08) Conference Call
Results
Show more

FY2008 3Q Consolidated Financial Overview
Toshiaki Itagaki, General Manager, Finance & Accounting Dept.
Overview of R&D Activities
Yutaka Tanaka, Vice President, General Manager of Clinical Development Div.
- Presentation [PDF 177KB]
Sep 02,2008
Media Conference on Avastin
Products / R&D
Show more

1)Overview of Avastin and Assessment of its Proper Use in Japan
Kosuke Iijima,
Avastin Product Manager
2)Progress in the Treatment of Metastatic Colorectal Cancer
One Year After the Launch of Avastin
Yasuhide Yamada,
Gastrointestinal Oncology Division,
National Cancer Center Hospital, Japan
- Overview of Avastin and Assessment of its Proper Use in Japan [PDF 713KB]
- Progress in the Treatment of Metastatic Colorectal Cancer [PDF 1,005KB]
Aug 01,2008
Information Meeting on 2008.12 Half-Year Financial Results
Results
Show more

1)FY2008 Interim Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President & CFO
2)Overview of R&D Activities
Tatsuro Kosaka, Senior Vice President
Head of Lifecycle Management Marketing Unit
- FY2008 Interim Consolidated Financial Overview [PDF 204KB]
- Overview of R&D Activities [PDF 118KB]
May 22,2008
Information Meeting on Actemra
Products / R&D
Show more

1)Product Overview of Actemra
Tadao Shimizu,
Actemra Product Manager
Chugai Pharmaceutical Co., Ltd.
2)Treatment evolution
- from "alleviating & delaying" to "stopping" disease progression -
Tsutomu Takeuchi, MD. PhD.
Vice Dean of Saitama Medical School
Professor of Medicine, Division of Rheumatology, Clinical Immunology Saitama Medical Center, Saitama Medical University
- Product Overview of Actemra [PDF 991KB]
- Treatment evolution - from "alleviating & delaying" to "stopping" disease progression - [PDF 582KB]
Apr 22,2008
1Q Results (Jan 08 - Mar 08) Conference Call
Results
Show more

FY2008 1Q Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
Overview of R&D Activities
Mikio Arisawa, Senior Vice President, Research, Head of Portfolio Management Unit
- Presentation [PDF 186KB]
Mar 03,2008
Media Conference on Herceptin
Products / R&D
Show more

1)Herceptin
Takahiro Yamaguchi,
Oncology Unit, Breast Cancer Group, Herceptin Product Manager
Chugai Pharmaceutical Co., Ltd.
2)Adjuvant Therapy with Trastuzumab
Hiroji Iwata, M.D.
Department of Breast Oncology, Aichi Cancer Center Hospital
3)Pharmacoeconomics of Trastuzumab (Herceptin)
Takashi Fukuda, Ph.D.
Department of Health Economics and Epidemiology Research
Graduate School of Medicine, The University of Tokyo
Jan 31,2008
Information Meeting on FY 2007.12 Financial Results
Results
Show more

1)New Mid-Term Business Plan "Sunrise 2012"
Osamu Nagayama, President and CEO
2)FY2007 Consolidated Financial Overview
Ryuzo Kodama, Executive Vice President and CFO
3)Overview of R&D Activities
Tatsuro Kosaka, Senior Vice President,
Head of Strategic Marketing Unit and General Manager of Strategic Planning Dept.

The Latest Presentation Materials

NXT007: Study Session on ISTH Presentation for Investors

Past Presentation Materials

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

Reports & Downloads